Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Celsius Therapeutics

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
2018
11-50
Cambridge, Massachusetts, United States
BiotechnologynologyEmergency MedicineGeneticsHealth CarePrecision Medicine

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

148.M

Last Funding Amount

83.M

Last Funding Date

24-03-2022

Startup Stage

M&A

Lead Investors

Catalio Capital Management, S32, Third Rock Ventures, Casdin Capital, Amplitude Venture Capital

Revenue

$1M to $10M

People

Founders